SERPINE1 enrichment within the tumor microenvironment was also observed in (triple-negative) breast cancer, and inhibition strategies markedly limited the aggressive phenotype of respective breast cancer cells, even reduced radioresistance (65). The gene discussed is SERPINE1; the disease is neoplasm.